Incyclix Bio
incyclixbio.com
Biotechnology
Oncology Therapeutics
Health Care
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$26.2M
2 rounds on record
Latest round
$11.2M
Venture round · Aug 2025 · 14 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 6, 2025
Raised a round Venture round $11.2M · SEC Form D
Feb 22, 2022
Raised a round Venture round $15M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2025 | $11.2M | — | SEC Form D |
| Venture round | Feb 2022 | $15M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Incyclix Bio, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Patrick RobertsExecutive Officer, DirectorSEC Form D
Fredric EshelmanExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ETX-19477 is a selective PARG inhibitor designed to address DNA damage response vulnerabilities and expand precision treatment options for…
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
IDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells…
Creating neoantigens by design… …to transform cancer treatments into cures. ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE…
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
People
Patrick Roberts
Executive Officer, Director
Fredric Eshelman
Executive Officer, Director
Norman Sharpless
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Durham
United States
HQ
Norman Sharpless, MD
600 Park Offices Dr., Suite 300, Durham, NC 27713
Media
United States
Regional office
MEDIA INQUIRIES
600 Park Offices Dr., Suite 300, Durham, NC 27713